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Global systemic fungal infection, including meningeal cryptococcosis caused by the encapsulated 
yeast Cryptococcus spp, continue to rise in number, especially among HIV infected individuals. 
Infection occur through inhalation of spore which is abundant in the environment. Initially this 
fungus stay in the lungs for a certain time without causing any symptoms and when the host’s 
cellular immune status is depleted, it can uses monocyte as a vehicle to take them to the brain, 
using a mechanism called Trojan Horse mechanism. Normal alveolar macrophage as the first line 
of innate immune system in the lungs are supposed to phagocytose, internalized and then destroy 
it inside an organelle named phagolysosome. But Cryptococcus spp seemed to have a built in 
antiphagocytic mechanism to avoid destruction and even can multiply therein. The interaction 
between this clever yeast and the host’s phagocytic cells determine the course of the disease. 
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1. INTRODUCTION  
 
The number of infection caused by pathogenic or 
opportunistic fungi is continously increasing 
globally, in terms of morbidity and mortality, 
including Cryptococcosis caused by the yeast 
Cryptococcus neoformans; an abundant 
environmental fungal pathogens that is the 
leading cause of global fungal origin of meningitis 
[1,2].
 
Approximately 278,000 cases and 181,000 
deaths related to Cryptococcus happened 
globally each year and that number is 15% of 
AIDS-related deaths worldwide [3]. It is an 
opportunistic, facultative intracellular pathogen 
and beside HIV individuals, other risk groups are 
organ transplant recipients and chemotherapy 
recipients; although recently cases in 
immunocompetent individuals have also begun 
to be detected [1,3,4].  
 
The course of the disease actually begins with 
inhalation of yeast particles, it can be in the form 
of spores or desiccated yeast cells into the host 
lung, as its initial predilection organ. In an 
immunocompetent host, this fungus can be 
efficiently eradicated through an immune 
response including phagocytosis by an innate 
immune cell called alveolar macrophages (AMs), 
an immune response that occured earliest [5]. 
Host AMs represent the first line of defense 
against the fungus. Once phagocytosed by AMs, 
fungal cells are killed by a concerted mechanism, 
involving the host-cellular response [6]. If the 
cellular response is impaired, phagocytosis of the 
fungus may be detrimental for the host, since Cr. 
neoformans can grow within macrophages. 
Usually there is usually a time lag since the first 
time this yeast entered its host until it caused a 
clear and definite clinical manifestations [7]. 
 
This yeast interacts closely with innate immune 
cells of the lungs, leading to various fates, 
including fungal persistence within cells, and 
possibilities of dissemination of the yeast cells to 
the brain [7,8] Unfortunately, in an 
immunocompromised host with poor immune 
response, the yeast manage to thrive and avoid 
destruction by the host’s immune cells [9-11] The 
organism will then grow and then disseminate, 
with the aid of monocytes through the blood, a 
mechanism called the Trojan Horse Strategy. By 
using this approach, it can reach the central 
nervous system after crossing the blood brain 
barrier and resulting in meningioencephalitis [10]  
  
When I first started to write this review paper, I 
remember an old rock song entitled “When love 
and hate collide”, where to some extent 
reminded me to the interaction between 
macrophages and Cr. neoformans. There is a 
link between the ‘love for foreign objects’, namely 
the ability of macrophage to phagocytes, but 
unfortunately this clever encapsulated yeast has 
the ability to evade the host’s immune 
armamentarium, especially with its 
antiphagocytic properties, its properties that we 
hate. The macrophage-yeast interaction is 





Chronic infection by Cr. neoformans results from 
combination of altered host immune responses 
and the existence of virulence factors [11] By 
adjusting their existence inside the host’s inner 
condition, this microorganism showed us that 
they have mastered the bargaining of cellular vs 
parasite interaction [8,11] This minireview aimed 
to discuss how Cr. neoformans evade their host’s 
immune armamentarium. 
 
2. BIOLOGY OF Cryptococcus 
neoformans 
 
Cryptococcus neoformans is a basidiomycetous 
opportunistic yeast, present abundantly in the 
environment [12,13]. Cryptococcus neoformans 
grows in vegetative state as budding yeast and 
can be frequently isolated from pigeon guano 
and tree hollows. During the reproductive sexual 
stage, Cryptococcus manage to change its form, 
from yeast growth to hyphal growth [14]. 
Eventhough this yeast undergoes amazing 
morphological transition during its life cycle, 
Cryptococcus is not classified to be dimorphic 
because the shape of yeast cells are always the 
predominant form in the environment, abundant 
in number and even when found inside the 
human host. The morphological transition (yeast 
to hyphal) is never found to be responsible in 




The development of Cryptococcus is relevant to 
its pathogenicity, at least in three different 
development condition: 
  
(1) Spores that result from hyphal development 
during mating are truly infectious propagules 
where upon inhalation, spores (in addition to 
desiccated yeast) can stay and colonize the 
lungs of a host for a certain period without 
producing any side effect [15-17]. But when the 
host’s immune status is depleted, usually due to 
HIV infection, this resident Cr. neoformans might 











bloodstream and crosses the blood–brain barrier, 
ultimately colonizing brain tissue and leading to 
substantially fatal consequences if it is not cured 
properly [15-17]. 
 
(2) The phase of sexual reproduction also 
contributes to the existence of genotypic 
variability of Cryptococcus species inside the 
host, which may lead to improvement of 
Cryptococcus cell’s fitness and virulence [18], 
 
(3) Some genes located within the MAT locus are 
important during mating and during infection 
[12,19]. 
 
Therefore, the understanding of the relationship 
between the development of Cryptococcus and 
its life cycle is also crucial in terms of studying 
cryptococcal pathogenicity [13]. Its antigenicity 
can be detected and measured relatively 
compared to its number and development 
condition, and this approach could help to direct 
the timely initiation of antifungal therapy [20]. 
 
This organism can defend predation by various 
organisms in nature, ranging from protozoans to 
even metazoans, through several ready-made 
virulence properties [17] The free living Cr. 
neoformans is able to compete closely with other 
type of unicellular organisms, e.g, amoebas, 
paramecia, and to some extent this condition is a 
training ground for them before they established 
an infection in their host. Phagocytic amoeboid 
predators such as amoeba have been proposed 
to select for survival traits in soil microbes, 
including Cr. neoformans, that can also function 
in animal virulence by defeating phagocytic 
immune cells, such as macrophages. Several 
prior studies have shown that incubation of 
various fungal species with amoeba can enhance 
their virulence [21]. Inside their host’s body, it 
interacts with some type of cells dedicated to the 
innate immune response (macrophages or 
dendritic cells) that naturally exhibiting various 
propensities of phagocytosis and intracellular 
killing of substance considered as corpus 
alienum [22,5,8]. 
 
The fungus Cr. neoformans grows best under 
certain host-control conditions, including the 
availability of serum low glucose level, 5% CO2, 
and low Fe level, among others, the cells 
produce a characteristic and prominent capsule 
composed mostly of sugar (polysaccharides) 
[23,24]. The size of the capsule depend on 
certain condition, under harsh low nutrition 
condition, it might developed thicker capsule 
[24,25]. Capsule formation is actually part of its 
coping mechanism [17,26]. 
 
Under routine ordinary staining, e.g, Gram-
stained smears, Cr. neoformans appearance 
may be stain variably or even poorly with; the cell 
appearance might disturbed by the existence of 
the massive thick scale gelatinous non-staining 
capsule. This polysaccharide based capsule 
actually inhibits the yeast-like cells to absorb 
color during staining. In Gram staining, it may 
appear either as granular cells with Gram-
positive rounded inclusions impressed upon its 
cytoplasmic that coloured pale lavender or 
sometimes seen as Gram-negative lipoid bodies. 
Under the regular light microscope examination, 
the India ink stain is widely used for easy but 
reliable visualization of the capsule in clinical 
specimen of cerebral spinal fluid
 
[27].There is a 
‘easy to spot’ zone of clearance or clear "halo" 
around the sphreical cells due to the non-
absorbable portion of capsule that prevent 
particles of ink pigment to enter the capsule 
portion. This quick and easy method is reliable to 
identify Cr. neoformans. India ink stain is still 
considered the best methods of direct 
examination for identification of Cryptococcus 
spp from spinal fluid [24,27]. Unusual 
morphological forms actually are not common 
and uniformity of shape is usually made them 
very easy to recognize. For attempting to identify 
this yeast in tissue, expert suggest that the 
option of using mucicarmine stain might help to 
specifically staining the polysaccharide portion 
that located in the cell wall of Cr. neoformans.  
 
How to make a direct diagnosis without any 
delay is also a problem. Its predilection, first in 
the lung and then when it disseminate to the 
brain, make it more difficult to find. Cryptococcal 
antigen (CrAg) acquired from the liqour 
cerebrospinalis is thought to be the best 
screening for diagnosis of cryptococcal 
meningitis (CM) [28]. But unfortunately, this 
option have some limitation because the result 
might be questionable if the test conducted in 
HIV-positive patients. In adults living with HIV 
who have CM symptoms, serum CrAg negativity 
may rule out CM, while positivity should prompt 
induction early antifungal therapy if the option of 
lumbar paracentesis is not available, e.g lack of` 
resources to perform the procedure. Only in the 
first episode of CM, cerebrospinal fluid CrAg 













Fig. 1. Macroscopic appearance of Cryptococcus spp colony on Bird Seed Agar /BSA medium 
(A) and on Sabouraud Dextrose Agar/SDA medium (B), while (C) microscopic appearance of 
Cryptococcus spp with India Ink stain (400× magnification). (All pictures taken from specimens 
belonging to the department of Parasitology, Faculty Of Medicine, Universitas Kristen 
Indonesia, Jakarta Indonesia) 
 
Adaptation to the host environment (nutrients, 
pH, and free radicals), mechanism of immune 
evasion (which include phenotypic variations and 
the ability to behave as a facultative intracellular 
pathogen) that makes Cryptococcus to survive 
[8,11,26]. Cryptococcus neoformans has two 
phenotypic characteristics, the capsule and 
synthesis of melanin, that have a profound effect 
in the virulence of the yeast, because they both 
have protective effects for the fungus and at the 
same time induce host damage as virulence 
factors [22,15,17]. Finally, the mechanisms that 
result in dissemination and brain invasion are 
also of key importance to understand 
cryptococcal disease, a mechanism facilitated by 
its facultative intracellular properties and the 
ability of evasion cellular immune cells [7,9-11]. 
 
3. PHAGOCYTOSIS, FACULTATIVE 
INTRACELLULAR CRYPTOCOCCUS 
AND EVASION MECHANISM 
 
Phagocytosis is actually a series of receptor-
mediated manner that started with activation of 
the phagocyte cells, chemotaxis, attachment to 
the foreign particles and finally leads to the 
internalization of these foreign particles. This 
action takes place mostly inside the inner portion 
of phagocytic cells and then those succesfully 
internalized particles normally will be processed 
further for being crushed inside a vacuole named 
phagosome [29].
 
The size of internalized objects 
usually ≥ 0.5 μm [29,30]. Recognition by 
macrophages is a very important key process in 
generating immune response against invading 
pathogens; and recognition of pathogens 
occured through surface receptors present on 
the macrophage's surface [5]. 
 
Cells that have phagocytosis function, e.g. 
macrophages, neutrophils and dendritic cells are 
recognized by their capability to express a 
number of receptors on their outer surface that is 
responsible for phagocytosis; those receptors are 
meant to recognize, bind, and trigger the 
internalization of corpus alienum, which includes 
microorganism with obligate intracellular 
properties, cellular debris and even pieces that 
come from apoptotic cells [5,29-32]. After 
phagocytic uptake, ingested particles are 
processed further; and destroyed using several 
lytic enzymes, as they progress along certain 
degradative endocytic steps. This process 
followed by the formation of the mature 
phagolysosome inside the phagocytic cells [33]. 
All of these three different cells: macrophages, 
dendritic cells, and neutrophils reflect the first line 
of normal defense against any invading 
microorganisms, by protecting the host with a 
unique and specific method for the process of 
isolating, removing and in the end destroying any 
harmful object in the host [34,35].  
 
In term of infection, defining the exact 
mechanisms by which the host immune reaction 
is able to limit and minimize the impact of 
infection remains a grey area. Limitless studies 
on the sophisticated origin of multi-pathway host-
pathogen interactions still continues, including for 











organisms maintain their persistence without 
being eliminated or killed inside the host’s 
immune cells is to some extent still an enigma 
[9,29]. These microorganisms have the capability 
to stay, withstand and even multiply, both intra- 
and extracellularly, leading to more active and 
dynamic cross talk with all arms of the host 
immune system [36]. From this point of view, the 
act of phagocytosis actually is a two sided sword 
to the host; it can be considered either an 
opportunity or hindrance to microorganisms [37].  
 
Viruses, many bacteria, and some protozoa that 
are obligate intracellular parasites in origin can 
only multiply inside their host’s specific cells [38]. 
Without being inside a phagocytic cells, these 
microorganisms will soon be killed by other 
immune cells, because they will not be able to 
withstand the harsh condition outside their host’s 
specific cell. Other kind of pathogens, including 
some type of bacteria and fungi, have the ability 
to multiply and even survive in both condition, 
extra- and intracellularly [39]. The choice of 
microorganism’s lifestyle inside their host 
depends on the availability of specific pathogen's 
factors that can make them able to survive 
and/or on conditions that facilitting their existence 
inside the host [40]  
 
Facultative intracellular yeast, Cryptococcus spp, 
have thrived their built-in capability to avoid 
phagocytosis by two ways: (1) by blocking 
adhesion to and/or internalization by phagocytic 
cells and (2) deactivate some part or some 
function of the immune cells (will be discuss in 
following section) [9]. In order to withstand and 
multiply intracellularly, Cr. neoformans, a 
facultative intracellular pathogen, has built up 
unique factors that can organize their invasion 
and even be able to disseminate to a place that 
is far from its original place. This properties is 
mainly based on its ability to choose between the 
intra- and extracellular compartments [22,8]. The 
need to search for the right genes or factors of 
the pathogen (or on contrary the host) that might 
facilitate a certain lifestyle that facilitate their 
existence and well being should be studied more 
extensively because gaining those kind of 
information will benefit us on the development of 
novel prevention methods (e.g vaccines) and 
treatment strategies for not only to cure 
cryptococcosis but also, potentially, other 
intracellular microorganisms. 
 
Eventually, Cr. neoformans may rupture 
phagocytes by lysis or it may escape via 
vomocytosis, leaving the host cell intact, and 
then with the aid of monocyte they enter the 
central nervous system and causing 
Cryptococcal meningitis [22,5,7-10]. The ability of 
Cr. neoformans to exit cells non-lytically, without 
causing macrophage damage or death, avoids 
stimulation of the innate immune response and 
further allows dissemination of the pathogen to 
the brain, in order to fulfill their need of inositol 
[41]. Cryptococcus neoformans can also 
proliferate within immune cells and show 
remarkable adaptation during infection, including 
modulation of virulence mechanisms such as 
polysaccharide capsule expansion [25]. 
 
3.1 Capsule Formation  
 
Cryptococcus cell morphology's have a role on 
its virulence. It is mainly supported by the 
establishment of a sugar based capsule that 
cover the whole cell wall. The antigenic 
componenet of the capsule have the ability to 
impede the phagocytosis process of the fungus 
that is supposed to be done by macrophages, 
dendritic cells , and neutrophils; and further also 
blocks the internalization of fungal cells by 
endothelial cells [9,23,24] The first host defense 
that react against the invasion of Cr. neoformans 
conducted by alveolar macrophages (AM) [5]. 
The interaction between Cr. neoformans and 
macrophages partly also rely on the dynamic role 
of the capsule; and this will determine its fate and 
existence intracellularly. After internalized by 
macrophages, Cr. neoformans may (i) multiply 
rapidly and result in lysis of the macrophage, (ii) 
directly be killed by the macrophage or other 
phagocytic cells, or (iii) manage to live within the 
macrophage, maintain their number in an 
equilibrium condition for some time, while waiting 
for the possibilities of escape and reach the brain 
without making the host’s cell disrupted. Inside 
the lungs of the host, all three conditions are 
possible to happen at the same time in one host. 
Interestingly, more recent studies provide data 
that the capsule is able to inhibit phagocytosis 
and also prevent killing by macrophages [9]. 
 
 Studies have identified some genes and 
pathways that are involved in capsule production, 
e.g the CAP and CAS gene families and the 
STE12, UXS1, CHS3, MAN1, AGS1, GPA1, 
PKA1 and PKR1 genes; all of these genes are 
responsible for capsule formation or biochemical 
pathways that are related to capsule formation 
[42-44].
 
These genes and pathways that regulate 
capsule production during infection still remain to 
be exploited extensively, and this open the 











of this yeast. Acapsular cryptococci are fragile 
and easily internalized by neutrophils and 
macrophages, whereas on contrary, the form of 
encapsulated yeast are more resistant and 
difficult for phagocytosis [11,45]. Encapsulated 
cells are not resistant to phagocytosis but it 
seems that they still can keep their virulence; this 
suggests that there is probably other virulence 
properties of the capsule beside simply 
preventing phagocytosis [45]. In vitro, the 
dynamic modulation of this phagocytic process 
by the capsule is determined by (1) capsule size, 
(2) capsule structure and composition, (3) the 
presence or absence of serum, and (4) the 
availability of phagocytic cells.  
 
3.2 Antiphagocytic Protein 
 
Actually, microorganisms have developed 
several mechanisms to modulate the host 
immune system to increase their survival and 
propagation in the host. Their presence in the 
host is not only revealed by self-produced 
peptides but also through host-derived 
chemokines and active complement fragments 
[46,47] Beside the gene that is responsible for 
capsule formation, another crucial virulence 
properties of Cr. neoformans is the 
Antiphagocytic Protein 1 (App1), which prevents 
the alveolar macrophages from phagocytizing the 
yeast cell in its surrounding. Beside that, App1 
also facilitate melanization [48]. App1 that is 
located at the outer part of the cell wall inhibits 
phagocytosis by binding to complement 
receptors CR2 and CR3 and thus avoids 
phagocytosis mediated through these receptors 
[46,49,50].  
 
Furthermore, if these receptors are not available 
on the macrophage cell surface, the 
antiphagocytic activity of macrophage is actually 
missing [50]. App1 has been found in serum of 
infected patients [49].It is considered to modulate 
the interaction between Cr. neoformans and 
macrophages. Cr. neoformans app1 mutants is 
actually avirulent in immunocompetent host, 
because they are efficiently phagocytosed by 
alveolar macrophages [50]. 
 
The role of the gene App1 in the initial stages of 
cryptococcosis and the differing effects of App1 
on its host depends on the immune 
status/immune level, especially on the availability 
of cellular immune cells [8,15]. The effort to 
reveal the mechanisms that arrange its 
expression as well as how it govern the yeast 
susceptibility to certain antifungal drugs might 
help in determining better treatment option. 
 
Treatment of infection caused by Cryptococcus 
spp is crucial, especially if given at the very early 
stage of infection because it can change the 
prognosis of the patient [51-53]. Antifungals like 
amphotericin B and fluconazole or flucytosine to 
some extent are used widely all over the world to 
treat cryptococcosis. Antifungal combotherapy 
are more succesful in treating CM rather than 
monotheraphy regimen [52]. Usually for already 
confirmed CM patient, at the inital 1-week 
amphotericin B regimen given; it consist of 
amphotericin B (1 mg per kilogram per day 
administered intravenously) plus either 
fluconazole (1200 mg per day) or flucytosine 
(100 mg per kilogram per day) for 7 days, 
followed on days 8 through 14 by fluconazole 
(1200 mg per day) [53].  
 
Cryptococcus’s virulence factors have been 
shown to influence the susceptibility to certain 
antifungal drugs, and that is why more recent 
studies explore this topic as a more promising 
approach to succesfully treat the patient [54]. As 
in the study conducted by Ghaffar et al, [3] they 
examined the relationship between App1 and 
antifungal drugs. The fact that single 
amphotericin B in short term actually 
downregulates App1 expression while exposure 
to single fluconazole upregulates App1. In 
addition, App1 was found to increase the 
susceptibility of the yeast to both amphotericin B 
and fluconazole, while given in combination. This 
study is a very good example of how treating 
virulence factors of Cryptococcus spp might be 
promising. 
 
3.3 Which Cells is Responsible for 
Phagocytosis? 
 
The specific type of phagocytic cells may 
determine the outcome and progression of 
cryptococcosis [5]. In murine models of 
cryptococcosis study, rat and mouse alveolar 
macrophages will surely eradicate Cr. 
neoformans, without the necessity of the 
presence of serum or gamma interferon (IFN-γ) 
or other types of cytokines in the reaction [55]. 
Different stimulation of murine resident peritoneal 
cells by selectively opsonized encapsulated and 
acapsular Cr. neoformans gave an interesting 
result. Murine resident peritoneal macrophages 
actually are able to destroy acapsular 
Cryptococcus cells without prior macrophage 











eradicate encapsulated cells only if IFN-γ is 
available or in condition if yeast cells are 
previously opsonized with either fresh serum or 
an anticapsular antibody [56]. Cryptococcosis in 
animal model gave us a lot of important 
information, eventhough when it comes to human 
cases, it is not immediately readily available as a 
conclusion [57]. 
 
But on contrary to the result on rodent 
macrophage, human alveolar macrophages have 
built-in anticryptococcal activity; eventhough its 
fungicidal capability can be boosted after the 
addition of fresh serum [58]. But what was 
interesting,in contrast to murine macrophages, 
human macrophages have more ability to 
destroy the acapsular strains compared to the 
encapsulated strains.  
 
Activation of human alveolar macrophages by 
adding IFN-γ do not necessarily enhance its 
anticryptococcal activity but actually has an 
unwanted deleterious effect because a higher IL-
4/IFN-γ ratio contributes to a greater polarization 
toward the M2 phenotype, which makes 
macrophages more permissive and tolerant [59-
61]. Human blood monocytes or neutrophils, in 
fresh condition, have the ability to killCr. 
neoformans. However, if they are induced to 
differentiate into macrophages during in vitro 
culturing, their killing activity dissapear, although 
they can still prevent cryptococcal growth [60,61]. 
What factor actually make the loss of 
macrophage killing activity is still unclear, but 
perhaps may be because of the dissipated 
myeloperoxidase activity during macrophage 
differentiation. Although there is some clear 
differences in the process of yeast’s killing by 
human and murine macrophages that have been 
noticed, the relative importance of the murine 
model used as a model of human disease 
basically is supported by some similarity between 
the human and mouse pathologies of 
cryptococcosis. 
 
The complexity of relationship between Cr. 
neoformans and the human arsenal of 
phagocytic cells is far from clear eventhough 
there have been many research results obtained. 
Phagocytic cells are involved in fungal clearance, 
but their specific functions, separately or in 
groups, should be investigated more extensively, 
with consideration given to (1) what is their 
optimum milleu, (2) their relationship with other 
arms of the immune response (cellular and 
humoral), and of course (3) the specific factor(s) 
produced by the microorganism(s) that interfere 





Regarding the course of this host-pathogen 
relationship and adaptation, there is much to be 
learned about the possibility of decreasing the 
hate factor: “its ability to grow and disseminate 
within the host”. Thus, modulation of “the love 
factor”: the expression level of antiphagocytic 
factors that may play a crucial role in the 
outcome of the infection or disease progression. 
These factors may also reflect objectives                  
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